What Researchers Did
Researchers measured levels of a protein called fibronectin in 35 patients with carbon monoxide poisoning before and after they received hyperbaric oxygen therapy.
What They Found
Before treatment, all 35 patients with carbon monoxide poisoning showed a significant decrease in plasma fibronectin levels compared to a control group (P < 0.001 for both moderate and serious cases). After hyperbaric oxygen therapy, these fibronectin levels significantly increased and returned to normal within one week.
What This Means for Canadian Patients
This suggests that hyperbaric oxygen therapy could help restore important proteins in the blood of Canadian patients suffering from carbon monoxide poisoning, potentially aiding their recovery. Maintaining healthy fibronectin levels is important for tissue repair and overall health.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
This study was conducted with a relatively small number of patients in 1991, and the abstract does not detail a control group for the hyperbaric oxygen treatment itself.